clinicaltrialsarena12h
Genentech’s Itovebi combo hits overall survival endpoint in HER2- breast cancer
The Phase III trial saw a clinically meaningful benefit in overall survival with a combination of Itovebi alongside Ibrance ...
clinicaltrialsarena14h
Akero’s cirrhosis treatment shows promise in Phase IIb study
Akero Therapeutics has revealed preliminary outcomes from its Phase IIb study of EFX in individuals with compensated ...
clinicaltrialsarena11h
ITM’s radiotherapeutic beats out standard-of-care in Phase III trial
ITM Radiopharma’s Phase III trial of its targeted radiotherapeutic for patients with Grade 1 or 2 gastroenteropancreatic ...
clinicaltrialsarena12h
Allakos cuts 75% of workforce after chronic hives trial failure
A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
clinicaltrialsarena20h
OCT West Coast 2025: Efficient trials will help at all levels
Arena International’s Outsourcing in Clinical Trials West Coast 2025 will discuss patient centricity, diversity, and ...
clinicaltrialsarena18h
Fortress doses first subject in Phase II CMV vaccine trial
Fortress Biotech, Helocyte have announced the dosing of the first subject in the trial of Triplex for individuals who are ...